Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women
Authors:
- 1 September 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 16 (5) , 1014-1020
Abstract
Objective: The aim of the present study was to investigate the relationship of polymorphisms in the tumor necrosis factor (TNF)-α, TNF-β, and TNF receptor (TNFR) genes to circulating TNF, soluble TNFR (sTNFR) levels, and bone mineral density (BMD) in women. Methods: The TNF-α G(−308)A, C(−857)T, C(−863)A, T(−1031)C, TNF-β A252G, TNFRI A36G, TNFRII T676G, A1663G, A1668G, and C1690T polymorphisms were analyzed in 377 postmenopausal Korean women. The levels of serum TNF-α, TNF-β, sTNFRI, sTNFRII, and bone turnover markers were measured. BMD was examined by dual energy x-ray absorptiometry. Results: After adjustment for age, body mass index, and years since menopause, no significant differences in BMD of the lumbar spine and femoral neck and serum levels of bone turnover markers were detected, according to single polymorphisms in TNF and TNFR genes and combined polymorphisms. However, the frequencies of the TT genotype of TNF-α T(−1031)C polymorphism, the non-AA genotype of TNF-β A252G polymorphism, and the GG genotype of TNFRII A1663G polymorphism were significantly higher in osteoporotic women than in women with normal BMD, respectively (P < 0.05). The TNFRII T676G polymorphism affected the serum sTNFRI and sTNFRII levels. The serum sTNFRII levels in the CC genotype of TNFRII C1690T polymorphism were the highest, with a G or C allele dose effect, and the TNFRII G676C/C1690T haplotype genotype also affected serum sTNFRII levels. Conclusions: TNF-α T(−1031)C, TNF-β A252G, and TNFRII A1663G polymorphisms may be genetic factors for osteoporosis in Korean postmenopausal women, and the TNFRII T676G and C1690T polymorphisms and their combined polymorphism affected serum sTNFRII levels. The TNFRII T676G polymorphism also affected the serum sTNFRI levels.Keywords
This publication has 33 references indexed in Scilit:
- Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal womenMenopause, 2007
- Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean womenJournal of Bone and Mineral Metabolism, 2005
- The role of T lymphocytes in bone metabolismImmunological Reviews, 2005
- Association between vitamin D receptor gene haplotypes and bone mass in postmenopausal Korean womenAmerican Journal of Obstetrics and Gynecology, 2003
- The relationship among serum insulin-like growth factor-I, insulin-like growth factor-I gene polymorphism, and bone mineral density in postmenopausal women in KoreaAmerican Journal of Obstetrics and Gynecology, 2002
- Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean womenMenopause, 2001
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001
- Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cellsBone, 1999
- Genetic and Environmental Correlations Between Bone Formation and Bone Mineral Density: A Twin StudyBone, 1998
- Environmental and genetic factors affecting bone mass similarity of bone density among members of healthy familiesArthritis & Rheumatism, 1995